Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease antiphospholipid syndrome
Comorbidity C0040053|thrombosis
Sentences 36
PubMedID- 25319344 At age 25 years, she experienced renal vein thrombosis, was diagnosed with antiphospholipid syndrome secondary to systemic lupus erythematosus, and was subsequently treated with prednisolone and warfarin.
PubMedID- 23811002 Heparin, low-molecular weight heparin and the synthetic pentasaccharide fondaparinux are commonly used for prophylaxis and treatment of thrombosis in patients with antiphospholipid syndrome.
PubMedID- 26150123 Connective tissue diseases: neutrophil extracellular traps-a mechanism of thrombosis in patients with antiphospholipid syndrome.
PubMedID- 22669753 The efficacy of long-term thromboprophylaxis and its associated risk of bleeding is a complex problem in apl-positive patients who have not developed previous thrombosis or in patients with antiphospholipid syndrome with isolated obstetric morbidity (i.e., rm).
PubMedID- 21048929 Since stent implantation may probably trigger acute thrombosis in patient with antiphospholipid syndrome, only the balloon dilatation of the lesion may be an alternative choice.
PubMedID- 20353974 This review covers recent studies that have used this approach for a better understanding of the pathogenic mechanisms involved in the development of thrombosis in patients with antiphospholipid syndrome (aps).
PubMedID- 20638238 A novel mechanism of thrombosis in antiphospholipid antibody syndrome.
PubMedID- 20659971 Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome.
PubMedID- 23073594 [analysis of risk factors in development of thrombosis in patients with antiphospholipid syndrome].
PubMedID- 24749249 [polymorphism of the plasminogen activator inhibitor type 1 gene, plasminogen level and thrombosis in patients with antiphospholipid syndrome].
PubMedID- 21188340 This unusual association of portal vein thrombosis with antiphospholipid syndrome in crohn's disease, observed according to our knowledge only in one other instance, raises the discussion regarding the convergent action of general thrombophilic (hereditary and acquired) and local factors in the genesis of vascular complications of inflammatory bowel diseases.
PubMedID- 21144335 [postpartum portal venous system thrombosis in a patient with antiphospholipid syndrome].
PubMedID- 21306376 Cardiovascular disease is common, with accelerated atherosclerosis, intravascular thrombosis associated with antiphospholipid syndrome, and hypertensive cardiomegaly.
PubMedID- 24449256 Management of recurrent thrombosis in antiphospholipid syndrome.
PubMedID- 24321419 Risk factors for arterial thrombosis in antiphospholipid syndrome.
PubMedID- 21245481 We have demonstrated using intravital microscopy that anti-beta(2)-gp1 autoantibodies purified from the sera of patients with antiphospholipid syndrome complicated by thrombosis greatly amplify thrombus size after laser-induced vessel wall injury in live mice.
PubMedID- 22957213 thrombosis within the context of antiphospholipid syndrome may occur even in histologically normal vessels.
PubMedID- 25895835 Bleeding and thrombosis in a patient with primary antiphospholipid syndrome using norethisterone: a case report.
PubMedID- 25864630 Background: long-term anticoagulation is recommended in antiphospholipid syndrome with thrombosis in order to prevent recurrences.
PubMedID- 24671503 To our knowledge, little is known about the value of mpv and its prognostic significance for thrombosis recurrence in patients with confirmed antiphospholipid syndrome.
PubMedID- 20487534 Two cases of anti-phospholipid syndrome with deep venous thrombosis associated with anti-cmv igm and igg antibodies have been reported [75,76].
PubMedID- 23817509 The objective of this study is to investigate the possible involvement of cd36 in the pathophysiology of thrombosis in patients with antiphospholipid syndrome (aps).
PubMedID- 25008944 Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity.
PubMedID- 20592997 Although formal studies are lacking at this time, we suggest the use of antiplatelet agents in combination with unfractionated or low-molecular-weight heparin to prevent recurrent stent thrombosis in patients with antiphospholipid syndrome or increased anticardiolipin antibody levels based on our experiences.
PubMedID- 25653707 Recurrent stent thrombosis in a patient with antiphospholipid syndrome and dual anti-platelet therapy non-responsiveness.
PubMedID- 25018941 A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (waps).
PubMedID- 26110520 Conclusion: this case report illustrates the rapid sequential venous and arterial ocular thrombosis in a patient with primary antiphospholipid syndrome.
PubMedID- 22721641 Higher levels of plasma matrix metalloproteinase-2 are associated with a significantly increased risk of arterial thrombosis in patients with the antiphospholipid syndrome.
PubMedID- 20564925 The paper describes a case of practically simultaneous development of the hemolytic-uremic syndrome (hus) and the catastrophic antiphospholipid syndrome (caps) complicated by mesenteric vessel thrombosis and small bowel necrosis.
PubMedID- 26424813 The cerebral venous sinus system is a rare site for venous thrombosis except in patients with antiphospholipid syndrome.
PubMedID- PMC4043440 3 cases started with thrombosis as manifestation of antiphospholipid syndrome (later confirmed by laboratory tests).
PubMedID- 21078423 Anti-beta (2)-glycoprotein i (anti-beta2-gp1) is one of the important pathogenesis factors responsible for thrombosis formation in patients with antiphospholipid syndrome (aps).
PubMedID- 22105547 Recurrent early miscarriages (excluding chromosomal anomalies), late fetal loss, and maternal thrombosis are characteristic of obstetric antiphospholipid syndrome (aps).
PubMedID- 20556336 [prosthetic valve thrombosis in a patient with antiphospholipid syndrome.
PubMedID- 20098808 Coronary thrombosis as a manifestation of the antiphospholipid syndrome is very uncommon.
PubMedID- 20490730 The causes of thrombosis in antiphospholipid syndrome (aps) remain unknown, though several hypotheses in regard to hypofibrinolysis have been proposed.

Page: 1